[Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism]. 2006

Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
Cardiovascular Department of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

OBJECTIVE To screen primary aldosteronism cases with ARR (aldosterone/plasma renin activity, ARR) from patients with hypertension, and to evaluate the diagnosis value of ARR in primary aldosteronism cases and analysis the clinical characters of primary aldosteronism cases. METHODS Nine hundred and two patients with hypertension were collected, the plasma aldosterone concentration to plasma renin activity ratio were detected by radio-immunity method, after that, ARR were calculated. Retrospective analysis was made of clinical data in 126 primary aldosteronism cases, which ARR were over 25. RESULTS One hundred and twenty-six cases (14%) were diagnosed as primary aldosteronism, and of them, 49 cases had hypokalemia. 25 patients received surgical operation and the rate of efficiency and cure of surgery treatment were 100% and 48%, respectively. The rate of efficiency and cure of drug treatment was 89% and 24% respectively. CONCLUSIONS Primary aldosteronism affects over 10% of patients with hypertension in China. Patients with hypertension and most patients with treatment-resistant hypertension should undergo screening for primary aldosteronism with ARR. A high ARR is a positive screening test result, a finding that warrants confirmatory testing.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer

Related Publications

Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
November 1982, Archives of internal medicine,
Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
June 1997, Journal of human hypertension,
Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
December 1986, Acta endocrinologica,
Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
September 1996, Vnitrni lekarstvi,
Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
April 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
November 2002, Clinical chemistry,
Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
December 2022, The Journal of clinical endocrinology and metabolism,
Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
February 2004, Journal of hypertension,
Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
December 2002, Hypertension (Dallas, Tex. : 1979),
Hui-lan Zhang, and Zhen-jiang Liu, and Jiao-mei Shao, and Jiang-tao Yan, and Dao-wen Wang
June 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Copied contents to your clipboard!